FutureMS Study: Removing uncertainty. Predicting your FutureMS.

Have you recently been diagnosed with relapsing remitting MS and not yet started on disease modifying treatment?

FutureMS is a Scotland-wide study for people living in Scotland and who have recently been diagnosed with relapsing-remitting multiple sclerosis (RRMS). We will use clinical examinations, MRI brain imaging and genetics to try to predict how severe your MS will be.

What can you do?

You may be able to take part if you have been diagnosed with relapsing remitting MS in the past 6 months and have not yet started on disease modifying treatment.

Am I eligible?

People with newly diagnosed relapsing remitting MS may be eligible if they:

  • Are 18 years or over
  • Have been recently diagnosed with relapsing remitting MS but not yet started on disease modifying treatment
  • Are happy to have blood tests and MRI brain imaging
  • Are not taking part in any other clinical trial
  • You must be able to travel to one of our FutureMS study sites (Edinburgh, Dundee, Glasgow, Aberdeen)

What is involved?

Study visits consist of clinical examinations, MRI brain imaging and genetic testing (blood test). There are two visits each 12 months apart. 

The potential impact of FutureMS

Reducing uncertainty: When people are newly diagnosed with MS, they do not know what the future will hold. Most people experience occasional bouts of symptoms called 'relapses', but doctors cannot predict how often, or how severe these relapses will be. This can make it difficult for people to make decisions about their lifestyle, work and family. FutureMS aims to give people MS greater clarity about what their future may hold.

Targeting treatment: By supporting a more accurate prognosis for individuals, FutureMS will also help doctors to prescribe the right medication at the right time for the right person. This is sometimes called 'personalised medicine'.

Finding out more and getting involved

Further information and an online form to express your interest are available through the FutureMS study website future-ms.org or telephone 0131 465 9517 and ask to speak with the FutureMS research nurse.

This study is funded by Stratified Medicine Scotland Innovation Centre